Location History:
- Rochester, MN (US) (2009 - 2017)
- Fort Pierce, FL (US) (2017)
- Ft. Pierce, FL (US) (2018)
- Jacksonville, FL (US) (2018 - 2021)
Company Filing History:
9 out of 1,746 
2 out of 2,103 
Years Active: 2009-2021
Title: Keith L Knutson: Innovator in Cancer Immunology
Introduction
Keith L Knutson is a prominent inventor based in Rochester, MN (US), known for his significant contributions to the field of cancer immunology. With a total of 10 patents, he has developed innovative methods and materials that enhance our understanding of immune responses related to cancer.
Latest Patents
Among his latest patents, one notable invention is related to "Immunity to Folate Receptors." This document provides methods and materials for assessing immunity to folate receptors, including techniques for evaluating FRα immunity in mammals. Additionally, it outlines methods for stimulating immunity to these receptors. Another significant patent is focused on "HLA-DR Binding Peptides and Their Uses." This invention presents HLA-DR (MHC class II) binding peptides derived from ovarian and breast cancer-associated antigens, such as Human Epidermal Growth Factor Receptor 2 (HER-2/neu), Carcinoembryonic Antigen (CEA), Insulin Growth Factor Binding Protein 2 (IGFBP-2), and Cyclin D1. These immunogenic peptides have potential applications in cancer vaccines.
Career Highlights
Throughout his career, Keith has worked with esteemed organizations, including the Mayo Foundation for Medical Education and Research and the University of Washington. His work has significantly advanced the field of cancer research and immunotherapy.
Collaborations
Keith has collaborated with notable colleagues, including Lynn C Hartmann and Kimberly R Kalli, contributing to various research projects and innovations in cancer treatment.
Conclusion
Keith L Knutson's innovative work in cancer immunology has led to the development of valuable patents that enhance our understanding of immune responses and potential treatments for cancer. His contributions continue to impact the field significantly.